# SiteLabs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sitelabs

- Industry: Healthcare IT
- Headquarters: Anderson, US
- Website: www.sitelabsglobal.com
- Total disclosed funding: $2M
- Latest round: Seed (Nov 6, 2025)
- Investors on record: 3

## About

SiteLabs, Inc, based in the US, provides innovative tools for point-of-care testing, empowering independent pharmacies to enhance their operational efficiency and patient care through streamlined workflows and secure testing services.Founded in 2020 and headquartered in Anderson, US, SiteLabs, Inc offers a point-of-care testing platform designed for independent pharmacies. The firm has completed two deals to date, with its latest funding round being a Seed round in which it raised USD 2.00 mn, led by Boomerang Ventures alongside LabCorp Ventures and the South Carolina Research Authority. The founder's background and prior ventures are not publicly detailed.SiteLabs offers a comprehensive point-of-care (POC) testing platform designed to enhance the operational efficiency of independent pharmacies across the United States. The core product enables pharmacies to streamline their testing workflow, allowing patients to schedule appointments online, make secure payments in advance, and receive test results through a HIPAA-compliant portal. The platform supports various compatible tests, including those for infectious diseases and diabetes, empowering pharmacies to meet their patients' healthcare needs while generating high-margin revenue without requiring additional staffing. The services cater to independent pharmacies, positioning them as vital healthcare providers in their communities, while also addressing the challenges posed by shrinking margins in the current healthcare landscape.The revenue model of SiteLabs is structured around direct transactions with independent pharmacies, focusing on the provision of testing services and the sale of testing supplies. Pharmacies partner with SiteLabs to access the testing platform, which may involve subscription arrangements or transactional fees based on the services utilized. The platform allows pharmacies to charge patients for tests, thereby creating a direct-to-consumer revenue stream. By offering a range of curated test kits and essential supplies, SiteLabs facilitates additional revenue opportunities for its clients. The financial arrangements for these products and services support the pharmacies in enhancing their profitability while addressing the evolving healthcare needs of their patient populations.SiteLabs, Inc plans to leverage its recent funding of USD 2.00 mn to enhance its product offerings and expand into new markets. The company aims to launch new testing solutions designed to meet the evolving healthcare demands by the end of the next fiscal year. Additionally, SiteLabs intends to broaden its reach to independent pharmacies in regions beyond its current operations, focusing on underserved markets across the United States as part of its growth strategy.

## Funding rounds

- Seed, Nov 6, 2025, $2M — South Carolina Research Authority, LabCorp Ventures, Boomerang Ventures

## Investors

- South Carolina Research Authority — Seed
- LabCorp Ventures (https://capitalatlas.ai/funds/labcorp-ventures) — Seed
- Boomerang Ventures (https://capitalatlas.ai/funds/boomerang-ventures) — Seed